Mechanical Dyssynchrony Is Not Everything of Substrate but Is Essential for Cardiac Resynchronization Therapy : Is Assessment of Mechanical Dyssynchrony Necessary in Determining CRT Indication? (Pro)
スポンサーリンク
概要
- 論文の詳細を見る
Cardiac resynchronization therapy (CRT) improves heart failure symptoms, cardiac function and long-term prognosis. As a result, it has been established as a treatment for refractory heart failure by using a specialized pacemaker to restore coordinated ventricular contractions with pacing. Despite being an invasive treatment, however, the above effects are not observed in 30-45% of patients selected based on the standard criteria that includes New York Heart Association class III or IV heart failure, left ventricular ejection fraction ≤35%, and QRS duration ≥120 or 130ms. From the fact that quantifiable resynchronization was associated with hemodynamic and clinical improvements, it should follow that mechanical dyssynchrony is a critical substrate for the benefits from CRT. The PROSPECT study unexpectedly demonstrated limitations of echocardiographic parameters using M-mode, pulsed-wave Doppler, and tissue Doppler imaging for accurately and reproducibly predicting response to CRT. However, advances in speckle tracking strain and real-time 3-D echocardiography have furthered the development of more sophisticated indices of dyssynchrony. Stress echocardiography might be useful for the detection of latent mechanical dyssynchrony in failing hearts. Because the substrate for CRT efficacy is multifactorial, a discriminant score that includes various clinical parameters and echocardiographic indices of mechanical dyssynchrony is needed to improve patient selection for CRT. (Circ J 2011; 75: 457-464)
- 2011-01-25
著者
-
Kanzaki Hideaki
Department Of Cardiology National Cardiovascular Center
-
Kanzaki Hideaki
Department Of Cardiovascular Medicine Heart Failure Division National Cerebral And Cardiovascular Ce
関連論文
- PJ-651 Predictors of the Improvement in Left Ventricular Ejection Fraction in Non-Ischemic Dilated Cardiomyopathy during Beta-Blocker Therapy(PJ109,Heart Failure (Treatment) 3 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
- PJ-504 Aortic Pulse Wave Velocity can Predict Left Ventricular Diastolic Dysfunction in a Community-based Population(PJ085,Heart Failure (Pathophysiology) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society
- PJ-489 Intraventricular Septal Intramural Asynchrony in Patients with Dilated Cardiomyopathy Using Tissue Velocity Imaging Correlates with the Severity of Myocardial Fibrosis(PJ082,Echo/Doppler (Myocardium) (I),Poster Session (Japanese),The 73rd Annual Sc
- PE-357 Does Preoperative Left Atrial Dilatation Predict Adverse Events after Aortic Valve Replacement?(PE060,Valvular Heart Disease (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PE-254 "Cardiac Anemia" is an Independent Predictor of Prognosis in Patients with Non-Ischemic Chronic Heart Failure(PE043,Heart Failure (Biomarker) 1 (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PE-034 Negative Impact of Cardio-renal Anemia Syndrome on Beta-blocker Tolerance and Subsequent Major Adverse Cardiac Events in Chronic Heart Failure(PE006,Kidney/Renal Circulation/CKD 1 (H),Poster Session (English),The 73rd Annual Scientific Meeting of T
- PJ-504 Aortic Pulse Wave Velocity can Predict Left Ventricular Diastolic Dysfunction in a Community-based Population(PJ085,Heart Failure (Pathophysiology) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society
- 1 Dyssynchrony was the Most Powerful Predictor for Benefits from CRT(Is assessment of mechanical dyssynchrony necessary in determining CRT indication?,Controversy 4 (C-4) (M),Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation S
- PJ-504 Aortic Pulse Wave Velocity can Predict Left Ventricular Diastolic Dysfunction in a Community-based Population(PJ085,Heart Failure (Pathophysiology) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society
- Clinical Significance of Plasma Brain Natriuretic Peptide as a Noninvasive Marker of Disease Severity in Aortic Regurgitation(Valvular Heart Disease/Pericarditis/Cardiac Tumor 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)